Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRELEVD-Pilot Study of preoperative levosimendan in cardiac surgery patients with right ventricular dysfunction
2018-004063-31Phase 3Active
- Sponsor
- Fundación IMABIS
- Start
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of levosimendan in Right heart dysfunction (RHF) (2 arms), sponsored by Fundación IMABIS. Primary endpoint: Cardiac function of right ventricle. Started Jan 2019; status: active.
02
Drugs
levosimendan
03
Conditions
Right heart dysfunction (RHF)
Beyond the preview
Go deeper on 2018-004063-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-004063-31.